FFCD - Neoadjuvant radiotherapy combined with fluorouracil-cisplatin plus cetuximab in operable, locally advanced esophageal carcinoma: Results of a phase I-II trial (FFCD-0505/PRODIGE-3)

Neoadjuvant radiotherapy combined with fluorouracil-cisplatin plus cetuximab in operable, locally advanced esophageal carcinoma: Results of a phase I-II trial (FFCD-0505/PRODIGE-3)

Auteurs

Bernadette de Rauglaudre, Guillaume Piessen, Marine Jary, Karine Le Malicot, Antoine Adenis, Thibault Mazard, Xavier Benoît D’Journo, Caroline Petorin, Joelle Buffet-Miny, Thomas Aparicio, Rosine Guimbaud, Véronique Vendrely, Côme Lepage, Laetitia Dahan

Journal / Conférence

Clinical and Translational Radiation Oncology

Type de publication

Article

Etude

PRODIGE 3

Localisation

Oesophage